Global Limb/Leg Lengthening Surgery Market Size, Share, and COVID-19 Impact Analysis, by Procedure (Lengthening Over Nail, Prostheses, External Fixation), By End User (Ambulatory Surgical Centers, Specialty Clinics, Others), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) Analysis and Forecast 2022-2028
KEY MARKET INSIGHTS
The global limb/leg lengthening surgery market has been estimated to reach USD 4.1 million in 2021 to USD 5.4 million by 2028 and it is projected to grow at a CAGR of 8.5% during the forecast period. Limb/leg lengthening is a surgical treatment in which new bones are grown. To support the bone, the method employs the body's interior soft tissues, ligaments, blood arteries, and nerves. Cosmetic lengthening is included in the treatment, which is classified as orthopedic surgery. Patients seek limb/leg lengthening surgery for a variety of reasons, including leg length discrepancy, congenital deformity, injury, fracture, and distorted bone position. There are other medical issues driving market expansion include dwarfism, premature puberty, and tiny legs due to small height.
The rise of the cosmetics business has resulted in a greater focus on physical appearance and aesthetics, leading to an increase in the number of people choosing for cosmetic procedures all over the world. Another explanation for the rising number of people seeking cosmetic surgery is a changing opinion of beauty and appearance influenced by movies and social media. In addition, medical advances have enabled surgeons to do minimally invasive surgeries that are quick and easy to recover. Ambulatory care centers and specialty care centers have grown in popularity as medical technology has advanced and hazards have decreased. Healthcare advancements have resulted in better healthcare solutions, which has fueled market expansion. Advances in surgery are largely to blame for the rising number of persons seeking aesthetic intervention for limb/leg lengthening surgery.
COVID-19 ANALYSIS
Because of the rising number of COVID patients and the risk of spreading to additional patients, the market momentarily dropped as a result of the COVID-19 pandemic. Due to a lack of beds at hospitals, surgeries have been postponed or cancelled. However, as the world recovers from COVID thanks to the development of vaccines, the market for limb/leg lengthening surgery is likely to rise as more people choose for minimally invasive procedures. Market expansion has been fueled by an increase in cosmetic procedures as a result of breakthroughs in medicine and more inexpensive healthcare.
LATEST TREND
Increasing Collaboration with the Athletes and Olympians
Increasing celebrity endorsements with the athletes and Olympians have created rising marketability. The marketing of limb/leg lengthening surgery has increased due to the increased usage of social media influencers. A celebrity endorsement can help a company gain credibility and reach new customers. The celebrity impact refers to a person's ability to influence others.
DRIVING FACTORS
Rising Number of People Opting for Minimally Invasive Surgeries
Developing countries throughout the world are becoming more interested in minimally invasive surgical procedures as their purchasing power is improving. Furthermore, these procedures are gaining popularity due to their numerous benefits, including fewer side effects, fewer post-surgery complications, and a shorter recovery time. As a result, the increased use of minimally invasive procedures is increasing the demand for implantable medical devices in these regions.
Increase in Cosmetic Surgeries Due to Advances in Medicine and Affordable Healthcare
Gaining popularity of cosmetic surgeries with the help of advanced medical technologies is fueling the growth of the global limb/leg lengthening surgery market. The FDA recently approved a fully implantable internal bone transport system that can be used to restore bone abnormalities without the requirement of external fixation. Furthermore, phenomena such as nerve regeneration and the formation of new vasculature that occur during limb lengthening surgeries may have major consequences in the future for a variety of orthopedic and other medical disorders. of limb-lengthening cosmetic surgery due to the improvements in medical technology.
RESTRAINTS
Concerns Pertaining to High Initial Costs of the Surgeries
The advanced limb/leg lengthening surgery is more expensive than traditional surgeries are anticipated to restrict the growth of the global limb/leg lengthening surgery market during the forecast period. Limb/leg lengthening surgery incur higher maintenance cost and require more upkeep which has resulted in its increasing prices of it. Nonetheless, rising consumer preference for cosmetic surgery resulted in propelling the growth of global limb/leg lengthening surgery market.
SEGMENTATION
The global limb/leg lengthening surgery market is segmented by Procedure (Lengthening Over Nail, Prostheses, External Fixation), By End User (Ambulatory Surgical Centers, Specialty Clinics, Others) and Region. Based on the type, the market is categorized into Lengthening Over Nail, Prostheses, and External Fixation. Based on application, the market is categorized into Ambulatory Surgical Centers, Specialty Clinics, and Others. Based on the region, the market is categorized into North America, Europe, Asia-Pacific, South America, Middle East and Africa.
By Type
Based on the procedure segment, the global limb/leg lengthening surgery market is categorized into lengthening over nail, prostheses, and external fixation. The lengthening over nail segment has dominated the market share in 2020. The increase can be attributable to novel treatment options for lower-limb length disparities that have been established. The incidence and severity of problems associated with bone lengthening have decreased as a result of these new choices. The goal of bone length regeneration is to make a person's limbs equal in length. This helps to improve both cosmetic and functional appearance, which is fueling the segment's growth.
By Procedure
Based on the end user segment, the global limb/leg lengthening surgery market is categorized into ambulatory surgical centers, specialty clinics, and others. The ambulatory surgical centers held the largest market share of the global limb/leg lengthening surgery market. Because of rising public health awareness and government measures to provide ambulatory healthcare services, the number of outpatients has expanded dramatically. Ambulatory surgery centers have grown in popularity due to an ageing population, rising prevalence of chronic diseases, rising healthcare expenses, and technology developments. These facilities provide modern surgery with a shorter hospital stay, which is fueling the segment's expansion
REGIONAL INSIGHTS
The global Limb/Leg Lengthening Surgery Market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Asia Pacific region is dominating the market share of global limb/leg lengthening surgery market owing to the expansion of this regional market can be linked to an increase in the number of hospitals as well as an increase in medical tourism as a result of the expanding population. People are looking for new surgery choices as the number of people choosing for cosmetic surgery grows. The regional market is likely to be driven by a growing focus on healthcare and the development of healthcare infrastructure in China, Japan, India, and South Korea. However, North America region is anticipated to grow over the next few years owing to the increase could be attributed to the region's growing number of surgical centers. Furthermore, the regional market is likely to be driven by the presence of a well-established healthcare infrastructure as well as a high rate of cosmetic procedures. Technology integration has resulted in advancements in medical, leading in better treatment.
LIST OF KEY COMPANIES PROFILED:
- Orthofix Medical Inc
- Betz Institute
- NuVasive, Inc
- BLUE OCEAN SPINE GMBH
- CubaHeal
KEY INDUSTRY DEVELOPMENTS:
March, 2021- Blue Ocean Spine GmbH (BOS) announced acquisition of PROLIXO designing a new limb lengthening technology to address the shortcomings of existing devices.
February, 2021- Orthofix Medical OFIX just launched the FITBONE intramedullary lengthening technology in US and Europe. This most recent discovery is intended to aid the company's global expansion in the extremities business. The FITBONE intramedullary lengthening system has been approved by the Food and Drug Administration (FDA).
SEGMENTATION
By Procedure
- Lengthening Over Nail
- Prostheses
- External Fixation
By End User
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
By Region
- North America- U.S., Mexico, Canada
- Europe- UK, France, Germany, Italy
- Asia-Pacific- China, Japan, India
- Latin America- Brazil, Argentina, Colombia
- The Middle East and Africa- United Arab Emirates, Saudi Arabia
ARE YOU SEEKING COMPREHENSIVE INSIGHT ON VARIOUS
MARKETS?
CONTACT OUR EXPERTS TODAY
Speak to an Expert
Global Limb Leg Lengthening Surgery Market
- May-2022
- 1 4 0
- Global
- Healthcare-Medical-Devices-Biotechnology
Related Research
2022-2030 Global and Regional B-Cell Non-Hodgkin`s Lymphoma (NHL) Treatment Industry Production, Sa
February-2021
2022-2030 Global and Regional Organ Transplant Diagnostics Industry Production, Sales and Consumpti
February-2021
2022-2030 Global and Regional Prostacyclin Drug Industry Production, Sales and Consumption Status a
February-2021
2022-2030 Global and Regional Spinal and Bulbar Muscular Atrophy Treatment Industry Production, Sal
February-2021
2% Chlorhexidine Gluconate (CHG) Cloths-Global Market Status & Trend Report 2022-2030 Top 20 Countri
April-2021
2021-2027 Global and RegioAnal Nasal Gels Industry Production, Sales and Consumption Status and Pros
February-2021
2021-2027 Global and Regional 2019-nCoV Detection Server Industry Production, Sales and Consumption
February-2021
2021-2027 Global and Regional ? Collagen Quantitative Determination Kit Industry Production, Sales a
February-2021
2021-2027 Global and Regional Anti-TNF Monoclonal Antibody Industry Production, Sales and Consumptio
February-2021